Join PATH virtually at the 2021 American Society of Tropical Medicine & Hygiene Annual Meeting

PATH is a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises, and investors to solve the world’s most pressing health challenges. With expertise in science, health, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales solutions—including vaccines, drugs, devices, diagnostics, and innovative approaches to strengthening health systems worldwide.

PATH develops, evaluates, and optimizes new tools and approaches to combat malaria and neglected tropical diseases in partnership with ministries of health, national malaria control programs, academia, and the public and private sector. Advancements we make together have impact beyond a single disease. Interventions enable resilient health systems, like community health worker cadres; epidemic and pandemic preparedness, such as the integration of data and trends for malaria and other illnesses in national and subnational emergency operations centers; digital transformation, such as the PMI Community Digital Health Initiative to support integrated service delivery in 27 countries; and innovation and access, like vaccine development and implementation.

In 30 presentations and panels, PATH staff will share key findings on our work in malaria and neglected tropical disease control and elimination efforts, as well as public health insights from around the world. See a full list of our activities below. Follow the conversation online at #TropMed21 and via @PATHMalaria.

Community knowledge and perception on malaria prevention after introduction of new, dual active ingredient insecticide-treated nets (ITNs) in the health districts of Banfora, Gaoua, and Orodara in Burkina Faso

• Date & time: Nov 18, 8:20 a.m. ET
• Presenter: Moubassira Kagoné, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso
• Co-authors: Federica Guglielmo, Liverpool School of Tropical Medicine; Fatou Ouattara, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Aboubacar Fofana, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Samuel Poda, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Kenzie Tynuv, PATH; Gauthier Tougri, Programme National de Lutte contre le Paludisme, Burkina Faso; Moussa W. Guelbeogo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; N'Fale Sagnon, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Christelle Gogue, PATH; Molly Robertson, PATH; Adama Gansané, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso
• Description: Considering the emergence and intensification of insecticide resistance in key mosquito populations, dual active ingredient insecticide-treated nets (ITNs) that are effective against insecticide resistant mosquitoes have been developed. In 2019, standard pyrethroid, pyrethroid and piperonyl butoxide (PBO), and Interceptor® G2 (BASF) ITNs were deployed in Burkina Faso’s Gaoua, Orodara, and Banfora districts, respectively. This study was conducted to collect anthropological data and assess factors that could influence ITN uptake and usage.

Efficacy of the RTS,S/AS01E malaria vaccine administered according to different fractional and full dose regimens under conditions of natural exposure in African children aged 5–17 months: First results from a phase 2b randomized controlled trial

• Date & time: Nov 18, 12:45 p.m. ET
• Presenter: Aaron Samuels, Centers for Disease Control and Prevention
• Co-authors: Daniel Ansong, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Simon Kariuki, Centre for Global Health Research; Samuel Adjei, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Anne Bollaerts, GSK; Christian Ockenhouse, PATH; Nelli Westercamp, Centers for Disease Control and Prevention; Cynthia Lee, PATH; Lode Schuerman, GSK; Dennis Bii, Centre for Global Health Research; Lawrence Osei-Tutu, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Martina Oneko, Centre for Global Health Research; Marc Lievens, GSK; Anima Attobrah Sarfo, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Cecilia Atieno, Centre for Global Health Research; Danielle Morelle, GSK; Ashura Bakari, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Tony Sang, Centre for Global Health Research; Erik Jongert, GSK; Maame Fremah Koto-Mortty, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Kephas Otieno, Centre for Global Health Research; Francois Roman, GSK; Patrick Buabeng, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Yaw Ntiamoah, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital; Opokua Ofori-Anyinam, GSK; Tsiri Agbenyega, Kwame Nkrumah University of Science & Technology/Agogo Presbyterian Hospital
• Description: A phase 3 trial showed that RTS,S/AS01E has moderate vaccine efficacy against malaria in African children when administered according to a zero-, one-, and two-month primary schedule with a fourth dose given at 20 months. Subsequent controlled human malaria infection studies in malaria-naïve adults demonstrated improved vaccine efficacy of RTS,S/AS01E with a delayed third and/or fourth fractional dose. This presentation describes initial results of an ongoing phase 2b open label randomized, controlled trial in Kenya and Ghana evaluating the efficacy of RTS,S/AS01E fractional dose regimens under conditions of natural exposure.

Early experience and next steps in evaluation of the attractive targeted sugar bait for malaria control in Kenya, Mali, and Zambia

• Date & time: Nov 18, 3:00 p.m. ET
• Presenters: Mathias Mondy, Innovative Vector Control Consortium; Busiku Hamainza, National Malaria Elimination Centre, Zambia; Helen Jamet, Bill & Melinda Gates Foundation; Eric Ochomo, Kenya Medical Research Institute; Kafula Silumbe, PATH; Mohamed Traore, University of Science and Technology of Bamako
• Description: This symposium provides an overview of the research and development of a new vector control tool, the attractive targeted sugar bait (ATSB), undertaken by teams in Mali, Kenya, Zambia, and Liverpool together with the manufacturer and with contributions from global experts in vector biology, mathematical modeling, insecticide resistance, malaria epidemiology, and biodiversity. The ATSB targets the sugar feeding behavior of adult anopheline mosquitoes by attracting sugar-seeking mosquitoes to a bait station where they ingest a sugar meal laced with a lethal toxicant. Research teams will present findings from pre-trial entomological validation studies. This includes results from community deployment of attractive sugar baits in Kenya and Zambia in 2021 to confirm that local malaria vectors feed from the bait stations. Initial community engagement strategies and social science research findings that will guide subsequent engagement for the large-scale ATSB field trials will also be reviewed. To generate supplemental data on the potential impact of the ATSB in a low-transmission setting, an entomological field study was completed in northern Mali in late 2019. The Mali team will present results from this low-endemicity field trial. Key challenges, lessons learned, and next steps for the ATSB research program will be discussed.

Towards a next-generation malaria vaccine portfolio: innovations in malaria vaccine development

• Date & time: Nov 18, 3:00 p.m. ET
• Presenters: Regina Rabinovich, MESA Alliance, ISGlobal; Halidou Tinto, Institute of Research in Health Sciences; B. Kim Lee Sim, Sanaria Inc.; Simon Draper, University of Oxford; Hernando del Portillo, ISGlobal and Institut Germans Trias i Pujol; Ashley Birkett, PATH
• Description: The favorable review of the pre-erythrocytic Plasmodium falciparum candidate RTS,S vaccine in 2015 by the European Medicines Agency marked a milestone in the malaria vaccine development arena, fostering the development and testing of other malaria-vaccine concepts, such as whole sporozoite vaccines, blood-stage vaccines, or transmission-blocking vaccines. Notably, the last two decades have also seen some promising Plasmodium vivax candidates, as well as novel strategies and platforms for malaria vaccine design. This symposium will bring together the perspectives of four researchers representing the key challenges for malaria vaccines from the bench to the field to discuss the latest innovations in malaria vaccine development and how to move toward an enriched malaria vaccine portfolio.

Increasing coverage of community case management of malaria is associated with reduction in severe malaria and malaria inpatient deaths in Zambia

• Date & time: Nov 18, 3:30 p.m. ET
• Presenter: Ruth A. Ashton, Tulane University Center for Applied Malaria Research and Evaluation
• Co-authors: Busiku Hamainza, National Malaria Elimination Centre (NMEC), Zambia; Steven Bwalya, NMEC; Christopher Lungu, PATH; Marie-Reine I. Rutagwera, PATH; Travis Porter, Tulane University Center for Applied Malaria Research and Evaluation; Michael Hainsworth, PATH; Sarah M. Burnett, PATH; Hannah Slater, PATH; Thomas P. Eisele, Tulane University Center for Applied Malaria Research and Evaluation; John M. Miller, PATH
• Description: Community case management (CCM) of malaria has been intensively expanded across Zambia since 2013. However, data describing CCM impact in routine implementation settings are limited. This retrospective and observational study evaluates the impact of CCM expansion on inpatient malaria cases and deaths from 2015 to 2020 in seven provinces in Zambia, hypothesizing that increasing the number of malaria providers per population (through CCM expansion) reduces delays in treatment seeking, consequently reducing the proportion of individuals progressing from uncomplicated to severe malaria or malaria-related death.

Developing a multi-perspective approach to vector control decision-making

• Date & time: Nov 18, 5:15 p.m. ET
• Presenters: Abraham Mnzava, African Leaders Malaria Alliance; Molly Robertson, PATH; Jan Kolaczinski, World Health Organization; Ellie Sherrard-Smith, Imperial College London; Andrew Saibu, IVCC; Keziah Malm, National Malaria Control Program, Ghana
• Description: While large-scale population coverage with insecticide-treated nets (ITNs) and/or indoor residual spraying (IRS) is currently understood to be the most cost-effective approach to malaria vector control, many programs see value in moving toward more tailored and targeted plans, recognizing that one-size-fits-all approaches are harder to sustain and can complicate sub-national stratification designed to maximize impact and return on investment. Additionally, the increased costs of new vector control tools such as dual-active ingredient ITNs and new formulations of IRS insecticides are barriers for programs in many malaria-endemic countries. There is also a need to complement activities targeting other aspects of the transmission cycle including seasonal malaria chemoprevention, vaccines, and housing improvements. More consideration is needed to develop frameworks that allow for nuanced decisions and locally tailored approaches to vector control and its position within the wider control and elimination efforts. This symposium will examine three key components of a dynamic framework for vector control decision-making: guidance, impact, and market factors.

Will RTS,S/AS01 be the first malaria vaccine recommended as part of routine immunizations to reduce illness and death in African children?

• Date & time: Nov 19, 4:00 p.m. ET
• Presenters: Margaret Gyapong, University of Allied and Health Sciences; John Bawa, PATH; Eliane Furrer, World Health Organization; Rose Jalang’o, Kenya Ministry of Health; Don Mathanga, Malawi College of Medicine; Melissa Penny, Swiss TPH; An Vermeersch, GSK; Mary J Hamel, World Health Organization
• Description: In October, RTS,S/AS01 became the first malaria vaccine recommended for widespread use among children in sub-Saharan Africa and in other regions with moderate to high transmission by the World Health Organization (WHO). It is also the first vaccine recommended for use against a human parasite. This will be the first presentation of results from the Malaria Vaccine Pilot Evaluation (MVPE) following data review by expert advisory groups to WHO (the Strategic Advisory Group of Experts on Immunizations and Malaria Policy Advisory Group). Findings from the MVPE will be presented, as will the outcome of the expert review. Programmatic challenges in introducing the vaccine will be shared, as will development and supply considerations for a vaccine exclusively intended for use in low and middle income countries. Finally, results from updated mathematical models on impact and cost-effectiveness will be presented.

Building data integration and visualization platforms to help Emergency Operation Centers monitor malaria during public health emergencies - experience from the Democratic Republic of the Congo

• Date & time: Nov 20, 12:55 p.m. ET
• Presenter: Jimmy Anzolo, PATH
• Co-authors: Garyn De Bondt, PATH; Hornel Lama, Bluesquare; Jicko Bondole, PATH; Marie-Julie Lambert, Bluesquare; Thomas Warichet, Bluesquare; Romain Olekhnovitch, Bluesquare; Henry Ntuku, PATH; Grégoire Lurton, Bluesquare; Trad Hatton, PATH; Kammerle Schneider, PATH; Nicolas de Borman, Bluesquare; Hana Bilak, PATH; Hyacinthe Kaseya, National Malaria Control Programme, DRC; Gisèle Mbuyi, Ministry of Health Epidemiological Surveillance Department, DRC; Erick Katanga, Ministry of Health Health Management Information Systems Department, DRC; Eric Sompwe Mukomena, National Malaria Control Programme, DRC; Aron Aruna, Ministry of Health Epidemiological Surveillance Department, DRC
• Description: The potential impact of COVID-19 on malaria morbidity and mortality highlighted the need to track malaria trends in near real time and design integrated sustainable interoperable data systems to improve malaria surveillance. Emergency Operations Centers (EOCs) are often geared toward fast response to emerging crises, but the long-term monitoring of a multiplicity of concurrent public health challenges is harder to maintain. Creating platforms for data integration and visualization systems for malaria surveillance, as well as for the coordination, planning, and monitoring of malaria campaigns, represents a unique opportunity to reinforce EOC capacity and provide a model for their sustainability. This presentation describes the experience of engaging with the Ministry of Health in the DRC to support its EOC’s engagement to respond to COVID-19, all the while strengthening malaria burden reduction efforts and increasing the EOC’s efficiency in responding to other emergencies.

Opportunities and challenges in using SARS-CoV-2 environmental surveillance for public health decision-making

• Date & time: Nov 20, 3:00 p.m. ET
• Presenters: Vajra Allan, PATH; John Scott Meschke, University of Washington Department of Environmental and Occupational Health Sciences; Catherine Anscombe, Malawi-Liverpool Wellcome Trust Centre; Dev Raj Joshi, Tribhuvan University; M. Imran Nisar, Aga Khan University Department of Pediatrics & Child Health; Mercy Mvundura, PATH
• Description: Environmental surveillance (ES) of sewage and fecal sludge to monitor the presence of SARS-CoV-2 has the potential to complement clinical efforts to understand the prevalence of the virus to inform governmental response. However, interpretation of ES data varies and may not be effectively incorporated into public health decision-making. This session will look at some of the barriers and opportunities for the implementation of ES data into actionable outcomes in low-middle-income countries. Three themes will be explored: approaches to conducting ES in low-middle-income countries, methods of conducting costing and cost-effectiveness, and potential use cases and limitations of ES in low-middle-income countries.

Poster session A: Thursday, November 18, 11 a.m.–12:30 p.m. ET

Modeling the potential impact of antimalarial interventions in high-burden areas of Ethiopia

• Authors: Amir Siraj, PATH; Mebrahtom Haile Zeweli, Ministry of Health, Ethiopia; Asefaw Getachew, PATH; Gezahegn Biratu, PATH; Duncan Earle, PATH; Laurence Slutsker, PATH; John M. Miller, PATH; Hannah Slater, PATH

Poster session B: Friday, November 19, Noon–1:30 p.m. ET

First-in-human evaluation of a P. falciparum transmission-blocking monoclonal antibody

• Authors: Saskia C. van der Boor, Radboud University Medical Center; Merel J. Smit, Radboud University Medical Center; Stijn van Beek, Radboud University Medical Center; Jordache Ramjith, Radboud University Medical Center; Peter Pickkers, Radboud University Medical Center; Yimin Wu, PATH; Emily Locke, PATH; Kazutoyo Miura, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases; Robert W. Sauerwein, Radboud University Medical Center; Rob ter Heine, Radboud University Medical Center; Teun Bousema, Radboud University Medical Center; Christian Ockenhouse, PATH; Matthijs M. Jore, Radboud University Medical Center; Matthew B.B. McCall, Radboud University Medical Center

Improving malaria surveillance through robust facility catchment population estimation

• Authors: Justin Millar, PATH; Rohan Arambepola, Johns Hopkins Bloomberg School of Public Health, Malaria Atlas Project; John Miller, PATH; Adam Bennett, PATH; Chris Lungu, PATH; Marie-Reine Rutagwera, PATH; Busiku Hamainza, National Malaria Elimination Centre, Zambia; Ewan Cameron, Malaria Atlas Project; Hannah Slater, PATH

Malaria high-risk populations in Senegal: a mixed-methods study to inform targeted interventions

• Authors: Henry Ntuku, PATH; Moustapha Cisse, PATH; Ndack Diop, PATH; Tidiane Thiam, PATH; Abiboulaye Sall, PATH; Aichatou Barry Diouf, Ministry of Health, Senegal; Mama Moussa Diaw, Ministry of Health, Senegal; Senghor Cheikh Sadibou, Ministry of Health, Senegal; Jennifer Smith, University of California San Francisco Malaria Elimination Initiative; Yakou Dieye, PATH; Caterina Guinovart, PATH/IS Global; Adam Bennett, PATH/University of California San Francisco Malaria Elimination Initiative

Observational impact of insecticide treated nets on malaria incidence in 16 districts across Burkina Faso, Mozambique, Nigeria, and Rwanda

• Authors: Kenzie Tynuv, PATH; Julia Mwesigwa, PATH; Christelle Gogue, PATH; Joseph Wagman, PATH; Peder Digre, PATH; Baltazar Candrinho, National Malaria Control Programme, Mozambique; Adama Gansane, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Aimable Mbituyumuremyi, Rwanda Biomedical Center, Kigali, Rwanda; Emmanuel Obi, Malaria Elimination Programme, Nigeria; Okefu Oyale Okoko, Malaria Elimination Programme, Nigeria; Perpetua Uhomoibhi, Malaria Elimination Programme, Nigeria; Audu Bala Mohammed, Malaria Elimination Programme, Nigeria; Ali Onoja, Ibolda Health International; Dele Babarinde, Ibolda Health International; Binete Savaio, PATH; Michee Kabera, Rwanda Biomedical Center; Christen Fornadel, IVCC; Molly Robertson, PATH

Poster session C: Saturday, November 20, 11:00 a.m.–12:30 p.m. ET

Baseline entomological landscape across 16 New Nets Project pilot districts: preliminary data on vector bionomics

• Authors: Joseph Wagman, PATH; Moussa Wamdaogo Guelbeogo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Antoine Sanou, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Madou Tapsoba, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Adama Gansane, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Sagnon N’Fale, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Emmanuel Hakizimana, Rwanda Biomedical Center; Aimable Mbituyumuremyi, Rwanda Biomedical Center; Dulcisaria Jotamo, Programa Nacional de Controlo da Malária, Mozambique; Baltazar Candrinho, Programa Nacional de Controlo da Malária, Mozambique; Okefu Oyale Okoko, National Malaria Elimination Programme, Nigeria; Perpetua Uhomoibhi, National Malaria Elimination Programme, Nigeria; Emmanuel Obi, National Malaria Elimination Programme, Nigeria; Audu Bala Mohammed, National Malaria Elimination Programme, Nigeria; Adedapo Adeogun, Nigerian Institute of Medical Research; Sam Awolola, Nigerian Institute of Medical Research; Adesola Musa, Nigerian Institute of Medical Research; Babatunde Salako, Nigerian Institute of Medical Research; Julia Mwesigwa, PATH; Christelle Gogue, PATH; Kenzie Tynuv, PATH; Peder Digre, PATH; Christen Fornadel, IVCC; Molly Robertson, PATH

Bed net indicators and malaria prevalence among children aged 6 to 59 months one year after introduction of dual-active ingredient insecticide-treated bed nets in three health districts areas of Burkina Faso: preliminary results

• Authors: Harouna Sore, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Christelle Gogue, PATH; Siaka Debe, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; René N. Kinda, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Adama Ganou, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Casimir Tarama, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Gauthier Tougri, Programme National de Lutte Contre le Paludisme, Burkina Faso; N'Fale Sagnon, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Moussa W. Guelbeogo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Molly Robertson, PATH; Adama Gansané, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso

Clinical and sub-clinical antenatal malaria surveillance compared to test positivity rate and health facility incidence in three countries

• Authors: Molly Robertson, PATH; Adama Gansané, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Baltazar Candrinho, National Malaria Control Program, Mozambique; Perpetua Uhomoibhi, National Malaria Elimination Programme, Nigeria; Julia Mwesigwa, PATH; Peder Digre, PATH; Christelle Gogue, PATH; Kenzie Tynuv, PATH; Kyra Arnett, PATH; Joseph Wagman, PATH; Hannah Koenker, Tropical Health LLP; Rene N. Kinda, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Okefu Oyale Okoko, National Malaria Elimination Programme, Nigeria; Emmanuel Obi, National Malaria Elimination Programme, Nigeria; Dele Babarinde, Ibolda Health International; Ali Onoja, Ibolda Health International; Patrick Walker, Imperial College London; Rose Zulliger, President’s Malaria Initiative/Centers for Disease Control and Prevention; Julie R. Gutman, Centers for Disease Control and Prevention

Entomological survey in three health districts in Burkina Faso with pyrethroid, piperonyl butoxide-pyrethroid, and Interceptor G2 ITNs deployed

• Authors: Madou Tapsoba, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Joseph Wagman, PATH; Antoine Sanou, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Soumanaba Zongo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Hyacinthe K. Toe, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; René N. Kinda, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Fatoumata Cissé, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Tougri Gauthier, PATH; Christelle Gogue, PATH; N’Falé Sagnon, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Adama Gansané, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Robertson Molly, PATH; Moussa W. Guelbeogo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso

Estimating the malaria prevention impact of new nets: baseline results from observational analyses to evaluate the evidence generated during piloted dual active ingredient insecticide-treated net distribution in Nigeria

• Authors: Okefu Oyale Okoko, National Malaria Elimination Programme, Nigeria; Peder Digre, PATH; Perpetua Uhomoibhi, National Malaria Elimination Programme, Nigeria; Ibrahim Maikore, National Malaria Elimination Programme, Nigeria; Emmanuel Obi, National Malaria Elimination Programme, Nigeria; Adedapo Adeogun, Nigerian Institute of Medical Research; Ali Onoja, Ibolda Health International; Dele Babarinde, Ibolda Health International; Ibrahim Abdulrahman, Ibolda Health International; Sylvanus Otikwu, Ibolda Health International; Sam Awolola, Nigerian Institute of Medical Research; Babatunde Salako, Nigerian Institute of Medical Research; Adesola Musa, Nigerian Institute of Medical Research; Hannah Koenker, Tropical Health LLP; Christelle Gogue, PATH; Joseph Wagman, PATH; Molly Robertson, PATH; Audu Bala Mohammed, National Malaria Elimination Programme, Nigeria

Identification of a novel epitope in the circumsporozoite protein (CSP) C-terminal region bound by RTS,S/AS01 induced human antibodies

• Authors: Randall S. MacGill, PATH; Tossapol Pholcharee, Scripps Research; David Oyen, Scripps Research; Nathan Beutler, Scripps Research; Wayne Volkmuth, Atreca, Inc.; Daniel Emerling, Atreca, Inc.; Thomas Rogers, Scripps Research; C. Richter King, PATH; Ian Wilson, Scripps Research

Integrating G6PD point-of-care testing into malaria case management to support radical cure: an assessment of health worker skills and knowledge in Laos and Vietnam

• Authors: Sarah Cassidy-Seyoum, University of California San Francisco Malaria Elimination Initiative; Huyen Nguyen, PATH; Sengkeo Vongviengxay, University of California San Francisco Malaria Elimination Initiative; Keoboupaphone Chindavongsa, Center of Malariology, Parasitology and Entomology, Lao PDR; Viengxay Vanisaveth, Center of Malariology, Parasitology and Entomology, Lao PDR; PhucQuang Bui, National Institute of Malariology, Parasitology and Entomology, Vietnam; Mai Thi Tuyet Dang, National Institute of Malariology, Parasitology and Entomology, Vietnam; Timothy Finn, University of California San Francisco Malaria Elimination Initiative; Spike Nowak, PATH; Emily Gerth-Guyette, PATH; Adam Bennett, PATH; Gonzalo J. Domingo, PATH

Interim results from a mixed-method analysis of insecticide-treated net use across 16 districts in Burkina Faso, Rwanda, Mozambique, and Nigeria

• Authors: Kyra Arnett, PATH; Jenny Shannon, PATH; Nami Kawakyu, PATH; Federica Guglielmo, Liverpool School of Tropical Medicine; Adama Gansane, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Moubassira Kagone, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Aimable Mbituyumuremyi, Rwanda Biomedical Centre Malaria and Other Parasitic Diseases Division; Chantal Ingabire, University of Rwanda; Baltazar Candrinho, National Malaria Control Program, Mozambique; Hannah Koenker, Tropical Health Consulting; Perpetua Uhomoibhi, National Malaria Elimination Program, Nigeria; Okefu Oyale Okoko, National Malaria Elimination Program, Nigeria; Audu Bala Mohammed, National Malaria Elimination Program, Nigeria; Dele Barbarinde, Ibolda Health International; Sylvanus Otikwu, Ibolda Health International; Ali Onoja, Ibolda Health International; Molly Robertson, PATH

Massive open online courses (MOOC) for continuing education for public health professionals during the COVID-19 pandemic in the Democratic Republic of the Congo

• Authors: Branly Mbunga, Kinshasa School of Public Health, University of Kinshasa; Desire Mashinda, Kinshasa School of Public Health, University of Kinshasa; Garyn Debondt, PATH; Mamana Mbiyavanga, Kinshasa School of Public Health, University of Kinshasa; Eric Mukomena, National Malaria Control Program, DRC; Hornel Lama, Bluesquare, Belgium; Grégoire Lurton, Bluesquare, Belgium; Marie-Julie Lambert, Bluesquare, Belgium; Jimmy Anzolo, PATH; Henry Ntuku, PATH; Jicko Bondole, PATH; Jeanne Mundela, PATH; Aruna Abedi, Epidemiological Surveillance Division, DRC; Edna Harimenshi, PATH; Trad Hatton, PATH; Hana Bilak, PATH

Observational analysis of the impact of insecticide rotation for an indoor residual spraying program in the Upper West Region of Ghana 2016-2019

• Authors: Kenzie Tynuv, PATH; Joseph Wagman, PATH; Julia Mwesigwa, PATH; Christelle Gogue, PATH; Andrew Saibu, IVCC; Keziah Malm, National Malaria Control Program, Ghana; Ignatius Williams, AngloGold Ashanti Malaria Control Limited; Samuel Asiedu, AngloGold Ashanti Malaria Control Limited; Titus Tagoe, Ghana Health Service; Christen Fornadel, IVCC; Molly Robertson, PATH

Overview of malaria transmission from an observational study in four sub-Saharan African countries

• Authors: Julia Mwesigwa, PATH; Christelle Gogue, PATH; Joseph Wagman, PATH; Kenzie Tynuv, PATH; Peder Digre, PATH; Baltazar Candrinho, National Malaria Control Programme, Mozambique; Aimable Mbituyumuremyi, Rwanda Biomedical Center; Joseph S. Hermann, Rwanda Biomedical Center; Binete Savaio, National Malaria Control Programme, Mozambique; Okefu Oyale Okoko, National Malaria Elimination Programme, Nigeria; Perpetua Uhomoibhi, National Malaria Elimination Programme, Nigeria; Emmanuel Obi, National Malaria Elimination Programme, Nigeria; Audu Bala Mohammed, National Malaria Elimination Programme, Nigeria; Dele Babarinde, Ibolda Health; Ali Onoja, Ibolda Health; Adama Gansane, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Christen Fornadel, IVCC; Molly Robertson, PATH

Performance of Zambia’s National Malaria Elimination Programme community health workers

• Authors: Travis Porter, PATH; Elizabeth Chiyende, PATH; Todd Jennings, PATH; Marie-Reine Rutagwera, PATH; Chris Lungu, PATH; Michael Hainsworth, PATH; Busiku Hamainza, National Malaria Elimination Centre, Zambia; Thomas P. Eisele, Tulane University School of Public Health and Tropical Medicine; John M. Miller, PATH

Prevalence of malaria infection and coverage of malaria control interventions among pregnant women attending their first antenatal care visit in three health districts of Burkina Faso: interim results

• Authors: René N. Kinda, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Christelle Gogue, PATH; Siaka Debe, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Adama Ganou, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Sonia Ilboudo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Aladari Sagnon, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Casimir Tarama, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Mafama Siribie, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Gauthier Tougri, Progamme National de Lutte Contre le Paludisme, Burkina Faso; N'Fale Sagnon, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Moussa W. Guelbeogo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Julie R. Gutman, U.S. Centers for Disease Control and Prevention; Molly Roberston, PATH; Adama Gansané, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso;

Reliability of malaria indicators in health districts in Burkina Faso: effects of an integrated quality assurance program

• Authors: Siaka Debe, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Christelle Gogue, PATH; René N. Kinda, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Sonia Ilboudo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Gerard W. Nonkani, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Adama Ganou, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Gauthier Tougri, Programme National de Lutte contre le Paludisme, Burkina Faso; N'Fale Sagnon, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Moussa W. Guelbeogo, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso; Molly Robertson, PATH; Adama Gansané, Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso

Tracking malaria prevalence and intervention coverage estimates through antenatal care (ANC) attendees in Chadiza District, Eastern Province, Zambia: progress and lessons learned, March 2020–June 2021

• Authors: Chabu Kangale, PAMO Plus; Maximillian Musunse, PATH Plus; Caroline Phiri-Chibawe, PAMO Plus; Busiku Hamainza, National Malaria Elimination Centre, Zambia; Paul Psychas, President’s Malaria Initiative; Lizzie Heilmann, President’s Malaria Initiative; John M. Miller, PATH; Travis Porter, PATH; Julie R. Gutman, Centers for Disease Control and Prevention

The use of digital technologies in community health programs: A landscape analysis of the U.S. President’s Malaria Initiative’s 27 partner countries

• Authors: Emily Carnahan, PATH; Monica Kothari, PATH; Sarah Burnett, PATH; Henry Mwanyika, PATH; Ayano Ogawa, PATH; Kammerle Schneider, PATH; Anzel Schonfeldt, PATH; Zahra Lutfeali, PATH